TY - JOUR
KW - Adult
KW - Humans
KW - *Calcitonin Gene-Related Peptide
KW - Academies and Institutes
KW - Administration, Oral
KW - Antibodies, Monoclonal
KW - *Migraine Disorders
KW - Cprd
KW - Calcitonin gene-related peptide antagonists
KW - Migraine epidemiology
KW - Migraine preventive medications
AU - D. Kernick
AU - N. Kondori
AU - A. Pain
AU - J. Mount
AU - C. Appel
AU - M. Ranopa
AU - T. Gulati
AD - St Thomas Health Centre, Exeter, UK.
Eli Lilly and Company Ltd, Lilly House, Basing View, Basingstoke, Hampshire, RG21 4FA, UK.
Eli Lilly and Company Ltd, Lilly House, Basing View, Basingstoke, Hampshire, RG21 4FA, UK. pain_andrew@lilly.com.
AN - 38262999
BT - BMC Prim Care
C2 - PMC10807158
DO - 10.1186/s12875-023-02242-y
DP - NLM
ET - 2024/01/24
LA - eng
M1 - 1
N1 - 2731-4553
Kernick, David
Kondori, Nazanin
Pain, Andrew
Mount, Julie
Appel, Camilla
Ranopa, Michael
Gulati, Tania
Journal Article
Observational Study
England
BMC Prim Care. 2024 Jan 24;25(1):34. doi: 10.1186/s12875-023-02242-y.
PY - 2024
SN - 2731-4553
EP - 34
T2 - BMC Prim Care
TI - Preventive treatment patterns in the adult migraine population: an observational UK study over 7 years
VL - 25
ER -